Apr 11, 2024 · Carbapenem-resistant Enterobacterales (CRE) are germs resistant to one or several antibiotics called carbapenems. In 2017, CRE caused about 13,100 infections in …

Apr 12, 2024 · Understand the prevalence or incidence of carbapenemase-producing CRE (CP-CRE) in your jurisdiction by performing some form of regional surveillance for these …

carbapenemase-producing CRE to prevent transmission to other patients through targeted interventions, like Transmission-Based Precautions. Screening tests for patients and residents …

Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates were resistant to imipenem, meropenem, or doripenem, using antimicrobial susceptibility testing breakpoints. …

Carbapenem-resistant Enterobacterales (CRE): An urgent public health threat CRE, which stands for carbapenem-resistant Enterobacterales, are a family of germs that are difficult to treat …

About: CRE are a major concern for patients in healthcare facilities. Some Enterobacteriaceae (a family of germs) are resistant to nearly all antibiotics, leaving more toxic or less effective …

Facility guidance for control of Carbapenem-resistant Enterobacteriaceae (CRE) : November 2015 update - CRE toolkit [PDF - 381.20 KB] National Center for Emerging and Zoonotic Infectious …

Require and strictly enforce CDC guidance for CRE detection, prevention, tracking, and reporting. Make sure your lab can accurately identify CRE and alert clinical and infection prevention staff …

type-producing CRE evaluated at CDC have only been resistant to one carbapenem (ertapenem). In an attempt to simplify the CRE deinition as well as further increase the ability of the deinition …

Some of the most common CROs that can cause healthcare-associated infections include carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas …